Open original FDA record ↗Recall record
- FDA identifier
- Z-0742-2022
- Company in FDA record
- bioMerieux, Inc.
- FDA classification date
- Mar 14, 2022
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Invalid calibrations (out of range high) while using the product.
Source facts
- Action
- The recalling firm issued letters dated 2/9/2022 via Fed Ex Express Priority Overnight delivery service to their U.S. consignees. The letter described the issue, the impact to the user, and the required actions. Those actions included instructing the consignee to stop using and destroy any stock of the recalled lot and to complete the Acknowledgement Form and return it via email or FAX. The quantity discarded was to be completed on the Acknowledgement Form.
- Initiated
- 2022-02-09
- Root cause
- Nonconforming Material/Component
- Terminated
- 2026-04-01
- Distribution
- Distribution was made to CA, FL, GA, IL, IN, LA, MA, MD, ME, MO, NJ, NY, OH, PA, TX, VA, WI, and WV. There was government distribution but no military or foreign distribution.
- Recall number
- Z-0742-2022
- Recall status
- Terminated
- CDRH record ID
- 191956
- FDA classified
- 2022-03-14
- Recall event number
- 89568